Predictive factors of bacteremia in patients with febrile urinary tract infection: An experience at a tertiary care center

Infection

Volumn 42, Issue 4, 2014, Pages 669-674

  Lee, H ^a   Lee, Y S ^a   Jeong, R ^a   Kim, Y J ^a   Ahn, S ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Bacteremia; Febrile UTI; Predictive factors; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; BODY TEMPERATURE; BREATHING RATE; CLINICAL EXAMINATION; CLINICAL FEATURE; COHORT ANALYSIS; ESCHERICHIA COLI; FEMALE; FEVER; FLANK PAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INDWELLING URINARY CATHETER; KOREA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PREDICTION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; THROMBOCYTE COUNT; URINARY TRACT INFECTION; URINE CULTURE; ADOLESCENT; AGE; AGED; BLOOD; BLOOD PRESSURE; COMPLICATION; ESCHERICHIA COLI INFECTION; MIDDLE AGED; PATHOLOGY; TEMPERATURE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; BLOOD PRESSURE; CALCITONIN; COHORT STUDIES; ESCHERICHIA COLI INFECTIONS; FEMALE; FEVER; HUMANS; KOREA; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; TEMPERATURE; TERTIARY CARE CENTERS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84906790013     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0615-3     Document Type: Article

References (34)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113[Suppl 1A]:5S-13S. (Pubitemid 34756640)
2. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13:1-38.
3. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551-81. (Pubitemid 27445472)
4. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-34. (Pubitemid 23317334)
5. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20.
6. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997;15:148-51. (Pubitemid 27147031)
7. Brown P, Ki M, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics. 2005;23:1123-42. (Pubitemid 41637754)
8. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol. 2003;13:144-50. (Pubitemid 36143714)
9. Kim KS, Kim K, Jo YH, Kim TY, Lee JH, Lee SJ, et al. A simple model to predict bacteremia in women with acute pyelonephritis. J Infect. 2011;63:124-30.
10. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect. 2006;53:235-40. (Pubitemid 44417973)
11. Litke A, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, et al. The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection. 2013;41:799-809.
12. van Nieuwkoop C, Hoppe BP, Bonten TN, Van't Wout JW, Aarts NJ, Mertens BJ, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51:1266-72.
13. Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect. 2005;50:296-305. (Pubitemid 40533367)
14. Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, et al. Bloodstream infections in the elderly. Am J Med. 1989;86:379-84. (Pubitemid 19103903)
15. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49[Suppl 1]:S57-61. (Pubitemid 30399352)
16. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-8.
17. Su CP, Chen TH, Chen SY, Ghiang WC, Wu GH, Sun HY, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44:449-55.
18. Kim DY, Lee YS, Ahn S, Chun YH, Lim KS. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat. 2011;43:176-80.
19. Muller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121-9.
20. Kasem AJ, Bulloch B, Henry M, Shah K, Dalton H. Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department. Pediatr Emerg Care. 2012;28:1017-21.
21. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206-17. (Pubitemid 38971491)
22. Ha YE, Kang CI, Wi YM, Chung DR, Kang ES, Lee NY, et al. Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis. Scand J Clin Lab Invest. 2013;73:444-8.
23. Shen CJ, Wu MS, Lin KH, Lin WL, Chen HC, Wu JY, et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:807-14.
24. van Nieuwkoop C, Bonten TN, van't Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14:R206.
25. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34-41. (Pubitemid 46907302)
26. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510-3. (Pubitemid 36929083)
27. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med. 1992;1:281-7.
28. Tolkoff-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am. 1997;11:707-17. (Pubitemid 27445480)
29. Shigemura K, Tanaka K, Osawa K, Arakawa S, Miyake H, Fujisawa M. Clinical factors associated with shock in bacteremic UTI. Int Urol Nephrol. 2013;45:653-7.
30. Brown PD. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2002;4:525-8.
31. Kung CH, Ku WW, Lee CH, Fung CP, Kuo SC, Chen TL, et al. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study. J Microbiol Immunol Infect. 2013. 10.1016/j.jmii.2013.08.006
32. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents. 2010;36:284-7.
33. Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, et al. Emergence of extended-spectrum beta-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist. 2011;17:537-44.
34. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726-31.